Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?
Completed · Phase 2/Phase 3
Conditions studied: Lung Cancer, Heart Disease, COPD
In brief
This study compares the effects of a standard smoking cessation treatment, including one-time brief counseling and provision of nicotine patch plus an 8-week moderate intensity exercise program versus the same standard smoking cessation treatment plus equivalent contact control among 60 healthy women. We hypothesize that participants in the smoking cessation plus moderate intensity exercise condition will be more likely to quit smoking than participants in the smoking cessation treament plus contact control condition.
Key facts
- Study ID
- NCT00420160
- Run by
- The Miriam Hospital
- People needed
- 59
- Starts
- 2007-02-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2015-04-14
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Healthy sedentary smokers (> 4 per day for at least one year)
- Ages 18 to 65 years
- Must be able to give informed consent
- Must live in the area for the next 3 months
- Willing to use the nicotine patch to attempt smoking cessation
- Must receive consent to participate from primary care physician
You may not qualify if…
- Cannot read or write fluently in the English language
- Pregnancy or plans to attempt pregnancy
- 60 minutes or more per week of moderate or vigorous physical activity
- Smokes cigars, pipes, or uses smokeless tobacco at least once per week
- Currently in a quit smoking program
- Currently using NRT of any kind or using any other quit smoking method or treatment
- Never had an adverse reaction to the nicotine patch resulting in discontinuation of use
- Poor willingness or inability to comply with protocol requirements
- An employee of the Centers for Behavioral and Preventive Medicine
- Previous participant in Commit to Quit or Fit to Quit smoking cessation studies
- Another member of the household is or has been enrolled in this study
- Currently taking a medication that might impact heart rate response, including but not limited to:
- Acebutolol Atenolol Carvedilol Metoprolol Nadolol Pindolol Propranolol Timolol
- Medical problems:
- Cardiac disease of any kind such as angina, a history of myocardial infarction or valve disease including mitral valve prolapse. Anyone with an interventional procedure such as a stent
- Pain, discomfort (or other anginal equivalent) in the chest, neck, jaw, arms or other areas that may be due to ischemia
- Cerebrovasular disease such as stroke or history of transient ischemic attacks
- Peripheral vascular disease (such as claudication)
- Diabetes (both Type I and II)
- Chronic infectious disease (HIV, hepatitis) (hepatitis A is okay)
- Liver disease
- Cystic fibrosis (CF)
- Chronic obstructive pulmonary disease (COPD) (see asthma and bronchitis under questionable)
- Interstitial lung disease
- Emphysema
Where it is running
- The Miriam Hospital — Providence, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.